Yayınlar & Eserler

Yayın Ağı
Makaleler 4
Tümü (4)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (4)
Scopus (4)

1. Can we manage the melanocytic lesions with peripheral globules according to the grade of dysplasia?

Avcı C., Akın G. N., Lebe B., Şahin M. T., Fetil E.
The Australasian journal of dermatology , cilt.65, sa.4, ss.358-368, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

2. Rituximab treatment for refractory and moderate-to-severe pemphigus patients in the pandemic era: A single-center retrospective study

Avcı C., Akın G. N., Akarsu S., Aktan Ş.
DERMATOLOGICA SINICA , cilt.42, ss.31-38, 2024 (SCI-Expanded, Scopus) Creative Commons License

3. The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series.

Akın G. N., Avci C., Akarsu S.
Indian journal of dermatology , cilt.69, sa.1, ss.81-85, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

4. Pyoderma gangrenosum and Behçet's-like disease induced by secukinumab: a paradoxical drug reaction.

Avcı C., Akın G. N., Akarsu S., Lebe B.
The Journal of dermatological treatment , cilt.34, sa.1, ss.2235040, 2023 (SCI-Expanded, Scopus) identifier identifier identifier
Metrikler

Yayın

9

Yayın (WoS)

6

Yayın (Scopus)

6

Atıf (WoS)

1

H-İndeks (WoS)

1

Atıf (Scopus)

14

H-İndeks (Scopus)

1

Atıf (Scholar)

1

H-İndeks (Scholar)

1

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları